August 25, 2015
WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market. With this contract [...]
August 25, 2015
Bielefeld: LaVision BioTec, developers of advanced microscopy solutions for the life sciences, report on the work of Ali Ertürk, a Group Leader at the Institute for Stroke and Dementia Research (part of the Klinikum der Universität München) at the Ludwig Maximilians University in Munich, Germany. Dr Ali Ertürk has been using light sheet and 2-photon [...]
Epigenetic Proteins for Drug Discovery
August 25, 2015
St Charles, MO -- Eurofins Pharma Discovery Services announces the launch of its portfolio of epigenetic proteins for direct sale to epigenetic researchers and drug discovery scientists. These proteins are used in industry-leading epigenetic screening and profiling services also available through Eurofins Pharma Discovery Services, since 2012. Epigenetic analysis is an increasingly important area of [...]
SYGNIS signs non-exclusive distribution agreement for Australia with GeneWorks Pty Ltd
August 25, 2015
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and [...]
InDevR Collaborating with Scientists at St. Jude Children’s Research Hospital to Evaluate FluChip-8G
August 25, 2015
BOULDER, Colorado –– InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced today that the lab of Richard Webby, Ph.D., at St. Jude Children’s Research Hospital (St. Jude) will be aiding in the development of a new influenza diagnostic, including evaluating assay performance on non-seasonal influenza viruses. The FluChip-8G [...]
High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System
August 25, 2015
SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow includes a new advanced integrated fluidic circuit (IFC) and reagent kit that significantly increases throughput and ease-of-use, while simultaneously [...]
August 25, 2015
VANCOUVER, British Columbia -- STEMCELL Technologies Inc. has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.’s patented technologies for induced pluripotent stem cell (iPS cell) research. This agreement will enable STEMCELL Technologies to develop, manufacture, and distribute products that are optimized for cellular reprogramming. This [...]
MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer
August 25, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized on its leading bioinformatics software platform in order to rapidly launch its BRCA1/2 genomic testing program. MDL, based in Covington, KY, will utilize the PierianDx Clinical Genomicist Workstation™ 3.0 to jump-start its BRCA testing program. [...]
August 24, 2015
Pleasanton, California – The revolutionary RapidHIT® System from IntegenX delivered a stunning arrest in the UK last week. A suspect was arrested for a minor crime and swabbed for a DNA reference sample while in custody. His DNA profile was generated in less than two hours using the RapidHIT System at UK forensic laboratory, Key [...]
August 24, 2015
PLEASANTON, Calif. -- Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, [...]
